title: Increasing role for modified bismuth-containing quadruple therapies for Helicobacter pylori eradication.
authors.affiliation: Department of Medicine, Michael E. DeBakey VAMC, Baylor College of Medicine, Houston, TX, USA.
authors.forename: David Y
authors.initials: DY
authors.lastname: Graham
authors.affiliation: Institute for Biostructures and Bioimages (CNR), Molecular Biotechnology Center, University of Turin, Turin, Italy.
authors.forename: Sharmila
authors.initials: S
authors.lastname: Fagoonee
authors.affiliation: Department of Gastroenterology and Hepatology, S. Giovanni Battista Hospital, Turin, Italy - rinaldo_pellican@hotmail.com.
authors.forename: Rinaldo
authors.initials: R
authors.lastname: Pellicano
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D009942:Organometallic Compounds; D054328:Proton Pump Inhibitors; D008795:Metronidazole; D013752:Tetracycline; C002791:bismuth tripotassium dicitrate